StockStory Flags Chemed’s Growth and Margin Record After Rally
The publisher cited slower five-year sales growth and a declining adjusted operating margin while calling Chemed’s valuation fair.
Makkler Newsroom · Oct 9, 08:39 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $617.00 (+12.6%)
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO